CIK 0001808898 · Non-accelerated filer<br>Smaller reporting company
Benitec Biopharma Inc.
Sign in to watch- Ticker
- BNTC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- Phone
- (510) 780-0819
- Business address
- 3940 TRUST WAY, HAYWARD, CA, 94545
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-26 | SUVRETTA CAPITAL MANAGEMENT, LLC Director | Option exercise · Common Warrants | −576,347 | 0 | ||
| 2024-09-26 | SUVRETTA CAPITAL MANAGEMENT, LLC Director | Option exercise · Pre-Funded Warrants | −148,210 | 428,137 | ||
| 2024-03-06 | Banks Jerel A. Chief Executive Officer | Grant or award · Options (right to buy) | +466,554 | 466,554 | ||
| 2024-03-06 | Boston Megan Executive Director | Grant or award · Options (right to buy) | +200,004 | 200,004 | ||
| 2023-12-06 | Smith Edward F Director | Grant or award · Options (right to buy) | +35,000 | 35,000 | ||
| 2023-12-06 | Francis Peter Director | Grant or award · Options (right to buy) | +35,000 | 35,000 | ||
| 2023-12-06 | BUCHI J KEVIN Director | Grant or award · Options (right to buy) | +35,000 | 35,000 | ||
| 2023-08-11 | BUCHI J KEVIN Director | Purchase | +51,813 | 52,097 | ||
| 2023-08-11 | BUCHI J KEVIN Director | Purchase · Common Warrants (right to buy) | +51,813 | 51,813 | ||
| 2023-08-11 | Boston Megan Executive Director | Purchase | +25,907 | 25,907 | ||
| 2023-08-11 | Boston Megan Executive Director | Purchase · Common Warrants (right to buy) | +25,907 | 25,907 | ||
| 2023-06-13 | Boston Megan Executive Director | Grant or award · Options (right to buy) | +153,000 | 153,000 | ||
| 2023-06-13 | Banks Jerel A. Chief Executive Officer | Grant or award · Options (right to buy) | +356,900 | 356,900 | ||
| 2022-12-07 | Smith Edward F Director | Grant or award · Options (right to buy) | +12,000 | 12,000 | ||
| 2022-12-07 | BUCHI J KEVIN Director | Grant or award · Options (right to buy) | +12,000 | 12,000 | ||
| 2022-12-07 | Francis Peter Director | Grant or award · Options (right to buy) | +12,000 | 12,000 | ||
| 2021-12-09 | Oliveira Steven Michael 10% owner | Purchase | +10,553 | $3.04 | $32K | 1,000,000 |
| 2021-12-08 | BUCHI J KEVIN Director | Grant or award · Options (right to buy) | +12,000 | 12,000 | ||
| 2021-12-08 | Smith Edward F Director | Grant or award · Options (right to buy) | +12,000 | 12,000 | ||
| 2021-12-08 | Francis Peter Director | Grant or award · Options (right to buy) | +12,000 | 12,000 |
Page 4 of 5 · 90 trades